Related content

Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells

By Takano M.   Hasegawa R.   Fukuda T.   Yumoto R.   Nagai J.   Murakami T.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel

By Crowe A.  

European Journal of Pharmacology, Vol. 440, Iss. 1, 2002-04 ,pp. : 7-16

Elsevier

Access to resources Recommend Favorite

Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome

By  

Current Drug Metabolism, Vol. 10, Iss. 4, 2009-05 ,pp. : 322-328

Bentham Science Publishers

Access to resources Recommend Favorite

P-glycoprotein Potentiates CYP3A4-mediated Drug Disappearance during Caco-2 Intestinal Secretory Detoxification

By Chan Lauretta M.S.   Cooper Anne E.   Dudley Adam L.J.   Ford Dianne   Hirst Barry H.  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite

Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers

By Arima Hidetoshi   Yunomae Kiyokazu   Morikawa Tadatoshi   Hirayama Fumitoshi   Uekama Kaneto  

Pharmaceutical Research, Vol. 21, Iss. 4, 2004-04 ,pp. : 625-634

Springer Publishing Company

Access to resources Recommend Favorite